Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - bohv type i, strain difivac, ge-deletion mutant inactivated - emulsion for injection - . - live and inactivated viral vaccines - cattle - immunological - inactivated vaccine

United States - English - NLM (National Library of Medicine)

sanofi pasteur inc. - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tubersol tuberculin purified protein derivative (mantoux), is indicated to aid diagnosis of tuberculosis infection (tb) in persons at increased risk of developing active disease. the centers for disease control and prevention (cdc) have published guidelines regarding populations that would benefit from tuberculin skin testing (tst). current recommendations can be accessed at: http://www.cdc.gov/tb/publications/factsheets/testing.htm. previous bcg vaccination is not a contraindication to tuberculin testing. the skin-test results of bcg vaccinated persons can be used to support or exclude the diagnosis of tb infection. however, an fda-approved interferon gamma release assay is preferred over tuberculin skin test for persons 5 years of age and older who were previously vaccinated with bcg. (8) allergy to any component of tubersol or an anaphylactic or other allergic reaction to a previous test of tuberculin ppd is a contraindication to the use of tubersol. (see description and how supplied.) tubersol should not be administered to: - persons who have had a severe reaction (e.g., necrosis, blistering, anaphylactic shock, or ulcerations) to a previous tst, - persons with documented active tuberculosis or a clear history of treatment for tb infection or disease, (9) - persons with extensive burns or eczema.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tubersol, tuberculin purified protein derivative (mantoux), is indicated to aid diagnosis of tuberculosis infection (tb) in persons at increased risk of developing active disease. the centers for disease control and prevention (cdc) have published guidelines regarding populations that would benefit from tuberculin skin testing (tst). current recommendations can be accessed at: http://www.cdc.gov/tb/publications/factsheets/testing.htm. previous bcg vaccination is not a contraindication to tuberculin testing. the skin-test results of bcg vaccinated persons can be used to support or exclude the diagnosis of tb infection. however, an fda-approved interferon gamma release assay is preferred over tuberculin skin test for persons 5 years of age and older who were previously vaccinated with bcg. (9) allergy to any component of tubersol or an anaphylactic or other allergic reaction to a previous test of tuberculin ppd is a contraindication to the use of tubersol. (see description and how supplied) tubersol should not

United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tuberculin ppd is indicated as an aid in the detection of infection with mycobacterium tuberculosis . the standard tuberculin test employs the intradermal (mantoux) test using a 5 tu dose of tuberculin ppd.7 the 0.1 ml test dose of aplisol (tuberculin ppd, diluted) is equivalent to the 5 tu dose which has been clinically utilized and standardized with ppd-s. tuberculin skin testing is not contraindicated for persons who have been vaccinated with bcg and the skin-test results of such persons are used to support or exclude the diagnosis of m. tuberculosis infections.4 hiv infection is a strong risk factor for the development of tb disease in persons having tb infection. all hiv-infected persons should receive a ppd-tuberculin skin test.3 aplisol is contraindicated in patients with known hypersensitivity or allergy to aplisol or any of its components. aplisol should not be administered to persons who have previously experienced a severe reaction (e.g., vesiculation, ulceration, or necrosis) because of the sev

United States - English - NLM (National Library of Medicine)

padagis us llc - activated charcoal (unii: 2p3vwu3h10) (activated charcoal - unii:2p3vwu3h10) - activated charcoal 25 g in 25 g - poison adsorbent for emergency use to adsorb swallowed poisons

United States - English - NLM (National Library of Medicine)

natural creations, inc. - activated charcoal (unii: 2p3vwu3h10) (activated charcoal - unii:2p3vwu3h10), copper (unii: 789u1901c5) (copper - unii:789u1901c5), drosera rotundifolia (unii: qr44n9xpjq) (drosera rotundifolia - unii:qr44n9xpjq), ipecac (unii: 62i3c8233l) (ipecac - unii:62i3c8233l), lachesis muta venom (unii: vsw71ss07i) (lachesis muta venom - unii:vsw71ss07i), lobelia inflata (unii: 9pp1t3tc5u) (lobelia inflata - unii:9pp1t3tc5u), phosphorus (unii: 27ylu75u4w) (phosphorus - unii:27ylu75u4w), pulsatilla vulgaris (un - activated charcoal 30 [hp_x] in 1 ml - uses: temporarily relieves dry, spasmodic, irritating cough with hoarseness.** uses: temporarily relieves dry, spasmodic, irritating cough with hoarseness.**

United States - English - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - activated charcoal (unii: 2p3vwu3h10) (activated charcoal - unii:2p3vwu3h10) - activated charcoal 1 [hp_x] - dyspepsia, flatulence condition listed above or as directed by the physician

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

inactivated) suspension for injection 0.5ml pre-filled syringes (sanofi pasteur msd ltd - human poliovirus type 1 inactivated; human poliovirus type 3 inactivated; human poliovirus type 2 inactivated - suspension for injection

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

irbitskiy himfarmzavod jsc - activated charcoal - tablets - 250mg

Malta - English - Medicines Authority

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - influenza vaccine, split virion, inactivated - suspension for injection in pre-filled syringe - influenza vaccine (split virion, inactivated) a/victoria/4897/2022 (h1n1) pdm09 - like strain (a/victoria/4897/2022 ivr-238 15 µg a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227 15 µg b/austria/1359417/2021 - like strain (b/austria/1359417/2021 bvr-26 15 µg b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type) - vaccines